Ground-level proof points accumulating: management narrates several small, named, recent wins and treats them as the lea
The model's full reasoning — Q4 2022 call → NOWe need to analyze the transcript for two conditions: (1) at least three distinct, named/individually identifiable episodes from the recent period, and (2) management explicitly connects these episodes into a building pattern that is still early. Let's list episodes mentioned in the transcript: - Acquisition of LIVMOR assets, including Halo+ AFib detection system, three US patents, and technical team. This is a specific event. - Partnership with Evolved Manufacturing Technologies to build the HeartBeam AIMIGo device. This is a specific partnership. - Two new patents: European patent for 12-Lead ECG capability, and US patent for 12-Lead ECG smartwatch monitor. These are specific IP grants. - Appointment of Rob Eno as President and Dr. Peter Fitzgerald as Chief Medical Officer. These are specific hires. - FDA submission of HeartBeam AIMI platform, with questions from FDA, teleconference, written responses. This is a specific regulatory interaction. - Planned FDA submission for AIMIGo V1, expected soon, and V2 targeted for Q4. But these are future plans, not yet happened. - The SVB situation, but that's not a positive episode. Now, are these "episodes" from the recent period? Yes, they are specific events that occurred. However, the question asks for "small, concrete, ground-level wins" that are "individually identifiable" and "freshly occurred, operator-level facts". The acquisition of LIVMOR is a significant corporate action, not a small ground-level win. The partnership with Evolve is a manufacturing agreement, also not a small operational win. The patents are IP grants, which are specific but not operational wins. The appointments are personnel changes. The FDA interaction is a regulatory step. The question emphasizes "small, concrete, ground-level wins" like a customer signing, a site opening, a product shipping first units, etc. Here, the episodes are more corporate-level: acquisitions, partnerships, patents, appointments. They are not the kind of granular operational wins described. For example, there is no mention of a specific hospital adopting the product, a specific patient using it, a specific distribution deal, etc. The closest might be the partnership with Evolve, but that's a manufacturing partner, not a customer win.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| AU | AngloGold Ashanti's | Q2 2018 | 2018-08-20 | B |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
AU · Q2 2018 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...YES The transcript shows multiple specific, recent operational episodes: Kibali’s underground ramp-up with automated ore handling system and vertical shaft integration; Iduapriem’s CIL tank conversion and grade/tonnage gains; Sunrise Dam’s Recovery Enhancement Project plus new mining strategies; Tropicana’s second 6-MW ball mill installation; Siguiri’s CIL circuit milestone; and 338 tracked Operational Excellence projects.
BXP · Q1 2022 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...YES The transcript shows multiple distinct, named episodes from the recent period: the 73,000 sq ft recapture/release at 77 CityPoint with a 15% rent increase and 7.
CRGO · Q1 2024 → YESThe question is: Does management's account of the just-reported period rest on SEVERAL SMALL, CONCRETE, GROUND-LEVEL WINS THAT IT NAMES AND DESCRIBES INDIVIDUALLY — specific recent episodes from insid...